TrialBlood advances2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.
Madan Jagasia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it